Helen A. Mintz-Hittner
Department of Ophthalmology and Visual Science
University of Texas Health Science Center - Houston Medical School
6400 Fannin Street
Suite 1800
USA. Electronic address:
Name/email consistency: high
- Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors. Mintz-Hittner, H.A. Early Hum. Dev. (2012)
- Antivascular endothelial growth factor for retinopathy of prematurity. Mintz-Hittner, H.A., Best, L.M. Curr. Opin. Pediatr. (2009)
- Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Mintz-Hittner, H.A., Kuffel, R.R. Retina (Philadelphia, Pa.) (2008)
- VSX1 (RINX) mutation with craniofacial anomalies, empty sella, corneal endothelial changes, and abnormal retinal and auditory bipolar cells. Mintz-Hittner, H.A., Semina, E.V., Frishman, L.J., Prager, T.C., Murray, J.C. Ophthalmology (2004)
- Successful amblyopia therapy initiated after age 7 years: compliance cures. Mintz-Hittner, H.A., Fernandez, K.M. Arch. Ophthalmol. (2000)